FERM domain-containing proteins in prostate cancer progression.

被引：0
|
作者：
Tahmassebypour, B. [1 ]
Valderrama, F. [1 ]
机构：
[1] St Georges Univ London, Div Biomed Sci, London, England
来源：
MOLECULAR BIOLOGY OF THE CELL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
2425
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FERM domain-containing proteins are active components of the cell nucleus
    Borkuti, Peter
    Kristo, Ildiko
    Szabo, Aniko
    Kovacs, Zoltan
    Vilmos, Peter
    LIFE SCIENCE ALLIANCE, 2024, 7 (04)
  • [2] The roles and mechanisms of YTH domain-containing proteins in cancer development and progression
    Liu, Shuiping
    Li, Guohua
    Li, Qiujie
    Zhang, Qin
    Zhuo, Lvjia
    Chen, Xiaying
    Zhai, Bingtao
    Sui, Xinbing
    Chen, Ke
    Xie, Tian
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (04): : 1068 - 1084
  • [3] FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression
    Tianzhuo Wang
    Huiying Guo
    Lei Zhang
    Miao Yu
    Qianchen Li
    Jing Zhang
    Yan Tang
    Hongquan Zhang
    Jun Zhan
    Frontiers of Medicine, 2023, 17 : 714 - 728
  • [4] FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression
    Wang, Tianzhuo
    Guo, Huiying
    Zhang, Lei
    Yu, Miao
    Li, Qianchen
    Zhang, Jing
    Tang, Yan
    Zhang, Hongquan
    Zhan, Jun
    FRONTIERS OF MEDICINE, 2023, 17 (04) : 714 - 728
  • [5] Measuring Interactions of FERM Domain-Containing Sorting Nexin Proteins with Endosomal Lipids and Cargo Molecules
    Ghai, Rajesh
    Mobli, Mehdi
    Collins, Brett M.
    ENDOSOME SIGNALING, PT A, 2014, 534 : 331 - 349
  • [6] A Novel Role for FERM Domain-Containing Protein 3 in CKD
    Kennedy, Ciaran
    Doyle, Ross
    Gough, Oisin
    Mcevoy, Caitriona
    Mcanallen, Susan
    Hughes, Maria
    Sheng, Xin
    Crifo, Bianca
    Andrews, Darrell
    Gaffney, Andrew
    Rodriguez, Javier
    Kennedy, Susan
    Dillon, Eugene
    Crean, Daniel
    Zhang, Weijia
    Yi, Zhengzi
    Nair, Viji
    Susztak, Katalin
    Hirschhorn, Joel
    Florez, Jose
    Groop, Per-Henrik
    Sandholm, Niina
    Kretzler, Matthias
    Mckay, Gareth J.
    Mcknight, Amy Jayne
    Maxwell, Alexander P.
    Matallanas, David
    Dorman, Anthony
    Martin, Finian
    Conlon, Peter J.
    Sadlier, Denise M.
    Brennan, Eoin
    Godson, Catherine
    Genie Consortium
    KIDNEY360, 2024, 5 (12): : 1799 - 1812
  • [7] Dysregulation of selected annexin family proteins is associated with prostate cancer progression.
    Xin, W
    Chinnaiyan, AM
    Pienta, KJ
    Dhanasekaran, SM
    Ingold, C
    Rubin, MA
    JOURNAL OF UROLOGY, 2002, 167 (04): : 173 - 173
  • [8] Leptin contributes to prostate cancer progression.
    De Velasco, Marco A.
    Yamamoto, Yutaka
    Hatanaka, Yuji
    Kura, Yurie
    Ando, Naomi
    Fukushima, Emiko
    Nozawa, Masahiro
    Shimizu, Nobutaka
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2013, 73 (08)
  • [9] Immunotherapy of prostate cancer: identification of new treatments and targets for therapy, and role of WAP domain-containing proteins
    Galustian, Christine
    Vyakarnam, Annapurna
    Elhage, Oussama
    Hickman, Oliver
    Dasgupta, Prokar
    Smith, Richard A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 1433 - 1436
  • [10] Death Effector Domain-Containing Proteins
    M. Gudur Valmiki
    J. W. Ramos
    Cellular and Molecular Life Sciences, 2009, 66 : 814 - 830
12345